Search
Castle Biosciences Inc
CSTLAdd to Watchlist
32.520USD
-1.680-4.91%
Close 11-06 16:00（ET）
993.49MMarket Cap
LossP/E TTM
Today
-4.91%
5 Days
-12.49%
1 Month
-3.53%
6 Months
+63.99%
Year to Date
-16.40%
1 Year
-1.57%
Key Figures
34.560Open
35.690High
107.80KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.35%Turnover Ratio
34.200Prev. Close
31.810Low
3.54MTurnover
54.57P/E Static
2.11P/B
0.00%Div Yield TTM
-2.45%ROA
44.28052wk High
0.22Volume Ratio
18.25MNet Profit
30.55MShares
-0.4158EPS TTM
1.07Beta
-2.85%ROE
17.72252wk Low
11.24%Amplitude
74.24%Gross Margin
993.49MMarket Cap
7.48Reward/Risk
3.39%Risk Rate
Castle Biosciences Inc's Score
-0.08vs previous score
Forecast9.00
Financial Health7.28
Technical3.83
Valuation Dimensions8.03
Institutional Confidence10.00
Risk Assessment5.68
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Castle Biosciences Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Castle Biosciences Inc Latest Earnings Call Transcripts
Castle Biosciences (CSTL) Q3 2026 Earnings Call: Revenue Guidance Raised
Castle Biosciences Q3 2026 revenue rose 24% to $102.9 million as TissueCypher volume climbed 47%, prompting higher full-year guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.12/-0.37
Revenue / Forecast
102.89M/92.52M
Castle Biosciences Inc Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolCSTL
Number of employees761
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 7.87% |
| RTW Investments L.P. | 6.97% |
| Principal Global Investors (Equity) | 5.84% |
| Portolan Capital Management, L.L.C. | 5.70% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 36.52% |
| Investment Advisor/Hedge Fund | 35.47% |
| Hedge Fund | 12.02% |
| Research Firm | 3.94% |
Related Instruments
-0.40%
+2.63%
-3.23%
+1.73%
-3.36%
-2.90%
-2.75%
+3.10%
-2.46%
-1.48%
-2.62%
-1.80%
-4.23%
+1.31%
-0.78%
+0.79%
-0.30%
+5.33%
+1.73%
-2.05%Popular Instruments
51971.000
+680.400 (+1.33%)
27243.300
+278.800 (+1.03%)
7448.200
+68.200 (+0.92%)
12797.000
-1.000 (-0.01%)
59353.000
+1211.000 (+2.08%)
6271.100
+130.500 (+2.13%)
85.962
-3.895 (-4.33%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4126.400
+60.730 (+1.49%)
FAQs
What is the current price of Castle Biosciences Inc (CSTL)?
The current price of Castle Biosciences Inc (CSTL) is 32.52.
What is the symbol of Castle Biosciences Inc?
The ticker symbol of Castle Biosciences Inc is CSTL.
What is the 52-week high of Castle Biosciences Inc?
The 52-week high of Castle Biosciences Inc is 44.28.
What is the 52-week low of Castle Biosciences Inc?
The 52-week low of Castle Biosciences Inc is 17.72.
What is the market capitalization of Castle Biosciences Inc?
The market capitalization of Castle Biosciences Inc is 993.49M.
Is Castle Biosciences Inc (CSTL) currently rated as Buy, Hold, or Sell?
According to analysts, Castle Biosciences Inc (CSTL) has an overall rating of STRONG BUY, with a price target of 46.70.
What is the Earnings Per Share (EPS TTM) of Castle Biosciences Inc (CSTL)?
The Earnings Per Share (EPS TTM) of Castle Biosciences Inc (CSTL) is -0.42.